A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug

NCT01124747 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc